Access to Care

Evaluating the safety profile of mifepristone

April 22, 2024 - Mifepristone, commonly known as the abortion pill, is a medication used primarily for medically induced abortions as well as the management of Cushing's syndrome and uterine leiomyomas. Since its approval in 2000, mifepristone has been the subject of extensive research and scrutiny, although it has a favorable safety profile.  The safety evaluation of mifepristone has gained...


More Articles

FDA approves $4.25 million gene therapy for MLD

by Veronica Salib

Once again, the pharmaceutical industry has topped its existing astronomical prices with Lenmeldy, an FDA-approved gene therapy for children with pre-symptomatic late infantile, pre-symptomatic early...

SCOTUS to issue a decision on mifepristone in the coming months

by Veronica Salib

The Supreme Court of the United States (SCOTUS) has yet to decide on mifepristone access in the US; however, many predict that the decision will come by late spring, June or July 2024 at the latest....

WHO reports increasing rates of HIV drug resistance to dolutegravir

by Veronica Salib

Earlier this week, the World Health Organization (WHO) issued a news release stating that there are increased trends in human immunodeficiency virus (HIV) drug resistance to dolutegravir. Despite this...

Over-the-Counter Birth Control Will Be $20 Per Monthly Supply

by Veronica Salib

On March 4, 2024, Perrigo Company, the manufacturer of Opill, announced that a monthly supply of the hormonal birth control pill costs $19.99 and is now available for pre-order. The product — and...

Breaking Down the Cost of Sickle Cell Disease Gene Therapies

by Veronica Salib

Earlier this week, the Biden–Harris administration announced its plans to address the expensive price tag of sickle cell disease, looking for a way to widen access despite the cost. In an...

Exploring Prescription Discount Cards’ Role in Medication Adherence

by Editorial Staff

Since prescription discount cards were introduced into the United States market in the early 2000s, patients and providers have leveraged them to combat rising drug costs and make medications more affordable. By enhancing drug...

Ensuring Equal Clinical Trial Access Across Vulnerable Communities

by Editorial Staff

Clinical trials play a critical role in ensuring the widespread safety of medical products for patients by analyzing product efficacy, safety, and indications. Since clinical trial data is used to guide drug approvals and standards of care...

Pharmacy Workforce Conditions Drive 3-Day CVS, Walgreens Staff Walkout

by Veronica Salib

Through Wednesday, November 1, 2023, patients may have more difficulty obtaining prescriptions or getting vaccinated at their local pharmacy. According to a CNN report, CVS and Walgreens pharmacy...

How New Platforms Are Saving Patients $4 Billion on Prescription Drugs

by Veronica Salib

Today, Visory Health announced that it is ranked the fourth-largest prescription discount card in the United States, based on an analysis from IQVIA. The company revealed that it has saved 3.25 million...

Ozempic in the US Costs Over Five Times More Than in Other Countries

by Veronica Salib

As weight loss drugs like Ozempic, Wegovy, and Mounjaro become increasingly popular in the United States, the financial weight of these drugs poses a significant burden for the US healthcare system....

FDA Advisory Panel Favors Over-the-Counter Birth Control Pill: Opill

by Veronica Salib

Echoing the voices of multiple major healthcare organizations and public health leaders, a joint FDA advisory panel favored making a birth control pill available over the counter (OTC). FDA leaders...

Oral Ketamine Treatment: An Alternative to Ketamine Infusions

by Veronica Salib

Data from the WHO estimates that 230 million people globally have depression. Although many traditional treatments exist for depression, roughly 33% of people do not respond to medications. As a result, researchers have searched for...

Federal Judge Rules to Reverse FDA Approval of Abortion Pill

by Veronica Salib

On Friday, April 7, 2023, a federal judge in Texas ruled to reverse the approval of mifepristone, the abortion pill. The Trump-appointed judge, Mathew Kacsmaryk, was assigned to the Alliance for...

Ohio Attorney General Sues Pharmacy Benefit Managers Due to Collusion

by Veronica Salib

On Monday, March 27, 2023, Ohio Attorney General Dave Yost sued pharmacy benefit managers (PBMs) from multiple organizations for collusion on drug prices. The lawsuit names numerous defendants,...

Novo Nordisk Cuts Prices of Insulin Pens and Vials by Up to 75%

by Veronica Salib

By January 2024, Novo Nordisk plans to cut the prices of insulin pens and vials by up to 75%. The company is echoing strategies reported by Eli Lilly earlier this month, attempting to widen access to...

Eli Lilly Cuts Insulin Prices and Caps Monthly Out-of-Pocket Costs

by Veronica Salib

On Wednesday, March 1, 2023, Eli Lilly, a major insulin manufacturer in the United States, announced that it would cut its insulin prices by 70% and cap out-of-pocket costs to $35 per month. By the end...

How Naloxone Co-Prescribing Laws Can Facilitate Opioid Education

by Veronica Salib

Fueled by deceit from pharmaceutical companies and over-prescription, the opioid epidemic has continued to impact thousands of lives. Throughout recent years, public health organizations and healthcare professionals have been working to...

FDA Issues Draft Recommendation for Updated Blood Donation Guidelines

by Veronica Salib

On January 27, 2023, the FDA issued a press release linking its new draft recommendation for updated blood donation guidelines. These updated guidelines take a more modern and individual approach to...

Disease-Modifying Antirheumatic Drugs Effectively Treat Arthritis

by Veronica Salib

Arthritis, a chronic condition characterized by inflammation, is a common disease in the United States. Approximately 43.5% of people in the US living with arthritis experience some sort of limitation due to their condition. To manage...